Approval builds on established role of Rhapsido in CSU and highlights potential of BTK inhibition across immune-mediated ...

Novartis achieved Tier 1 status in the 2026 Corporate Mental Health Benchmark, recognizing its approach to workplace mental ...

. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result ...

Explore opportunities with Novartis below.

The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs. Most medicines are made the old-fashioned way. In ...

Manju Ujjini, Head of Lead Discovery for our Global Health Biomedical Research group, discusses what’s next for his team in drug discovery Manjunatha (“Manju”) Ujjini aims to discover medicines for ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

Gail Horwood is Chief Marketing and Customer Experience Officer at Novartis US, where she leads portfolio-wide marketing transformation. In this role she brings together cross-functional teams to ...

What drives someone to dedicate their career to reimagining medicine? Three women at Novartis share their deeply personal and unique stories. For Arti, Giselle and Maria their desire for purpose began ...